S&P 500   3,851.85
DOW   31,188.38
QQQ   324.93
S&P 500   3,851.85
DOW   31,188.38
QQQ   324.93
S&P 500   3,851.85
DOW   31,188.38
QQQ   324.93
S&P 500   3,851.85
DOW   31,188.38
QQQ   324.93
Log in
NASDAQ:AZRX

AzurRx BioPharma Stock Forecast, Price & News

$0.97
+0.05 (+5.57 %)
(As of 01/21/2021 09:15 AM ET)
Add
Compare
Today's Range
$0.93
Now: $0.97
$1.07
50-Day Range
$0.74
MA: $0.83
$1.04
52-Week Range
$0.37
Now: $0.97
$1.30
Volume128,828 shs
Average Volume5.83 million shs
Market Capitalization$33.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81
AzurRx BioPharma, Inc., a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. The company's therapeutic products are administered to patients as oral non-systemic biologics. Its lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency for cystic fibrosis and chronic pancreatitis patients. The company was incorporated in 2014 and is headquartered in Delray Beach, Florida.
AzurRx BioPharma logo

MarketRank

Overall MarketRank

1.40 out of 5 stars

Medical Sector

544th out of 1,928 stocks

Pharmaceutical Preparations Industry

270th out of 774 stocks

Analyst Opinion: 3.4Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AZRX
CUSIPN/A
Phone646-699-7855
Employees10

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.17 per share

Profitability

Net Income$-15,180,000.00

Miscellaneous

Market Cap$33.95 million
Next Earnings Date2/15/2021 (Estimated)
OptionableNot Optionable
$0.97
+0.05 (+5.57 %)
(As of 01/21/2021 09:15 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AZRX News and Ratings via Email

Sign-up to receive the latest news and ratings for AZRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AzurRx BioPharma (NASDAQ:AZRX) Frequently Asked Questions

How has AzurRx BioPharma's stock price been impacted by COVID-19 (Coronavirus)?

AzurRx BioPharma's stock was trading at $0.6150 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AZRX shares have increased by 49.9% and is now trading at $0.9216.
View which stocks have been most impacted by COVID-19
.

Is AzurRx BioPharma a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AzurRx BioPharma in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AzurRx BioPharma stock.
View analyst ratings for AzurRx BioPharma
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than AzurRx BioPharma?

Wall Street analysts have given AzurRx BioPharma a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AzurRx BioPharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as AzurRx BioPharma's CEO?

1,428 employees have rated AzurRx BioPharma CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 59% among AzurRx BioPharma's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is AzurRx BioPharma's next earnings date?

AzurRx BioPharma is scheduled to release its next quarterly earnings announcement on Monday, February 15th 2021.
View our earnings forecast for AzurRx BioPharma
.

How were AzurRx BioPharma's earnings last quarter?

AzurRx BioPharma, Inc. (NASDAQ:AZRX) announced its quarterly earnings results on Monday, November, 16th. The company reported ($0.47) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.12) by $0.35.
View AzurRx BioPharma's earnings history
.

What price target have analysts set for AZRX?

4 Wall Street analysts have issued 1-year price objectives for AzurRx BioPharma's stock. Their forecasts range from $2.00 to $3.00. On average, they expect AzurRx BioPharma's stock price to reach $2.50 in the next year. This suggests a possible upside of 171.3% from the stock's current price.
View analysts' price targets for AzurRx BioPharma
or view Wall Street analyst' top-rated stocks.

Are investors shorting AzurRx BioPharma?

AzurRx BioPharma saw a drop in short interest in December. As of December 31st, there was short interest totaling 111,200 shares, a drop of 35.7% from the December 15th total of 172,900 shares. Based on an average daily volume of 160,100 shares, the days-to-cover ratio is currently 0.7 days.
View AzurRx BioPharma's Short Interest
.

Who are some of AzurRx BioPharma's key competitors?

What other stocks do shareholders of AzurRx BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AzurRx BioPharma investors own include ADMA Biologics (ADMA), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), SCYNEXIS (SCYX), Gran Tierra Energy (GTE), Cogent Biosciences (UMRX), KushCo (KSHB), OrganiGram (OGI), Pennsylvania Real Estate Investment Trust (PEI) and Novan (NOVN).

Who are AzurRx BioPharma's key executives?

AzurRx BioPharma's management team includes the following people:
  • Mr. James R. Sapirstein R.Ph., M.B.A., CEO, Pres & Non-Independent Director (Age 59, Pay $443.61k)
  • Dr. James E. Pennington, Chief Medical Officer (Age 77, Pay $330k)
  • Mr. Martin Krusin M.B.A., Sr. VP of Corp. Devel.
  • Mr. Daniel H. Schneiderman, Chief Financial Officer (Age 42)

When did AzurRx BioPharma IPO?

(AZRX) raised $15 million in an IPO on Friday, September 9th 2016. The company issued 2,100,000 shares at a price of $6.00-$8.00 per share. WallachBeth Capital and Network 1 Financial Securities acted as the underwriters for the IPO.

What is AzurRx BioPharma's stock symbol?

AzurRx BioPharma trades on the NASDAQ under the ticker symbol "AZRX."

How do I buy shares of AzurRx BioPharma?

Shares of AZRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AzurRx BioPharma's stock price today?

One share of AZRX stock can currently be purchased for approximately $0.92.

How big of a company is AzurRx BioPharma?

AzurRx BioPharma has a market capitalization of $32.16 million. AzurRx BioPharma employs 10 workers across the globe.

What is AzurRx BioPharma's official website?

The official website for AzurRx BioPharma is www.azurrx.com.

How can I contact AzurRx BioPharma?

AzurRx BioPharma's mailing address is 760 PARKSIDE AVENUE SUITE 304, BROOKLYN NY, 11226. The company can be reached via phone at 646-699-7855 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.